drugset / Trial / NCT02273544
Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study was to compare the pharmacokinetics of dipyridamole in three different Asasantin ER batches (test) containing different amounts of retarding lacquers to the existing commercial product at steady state with b.i.d. treatment
Timeline
- Start
- 2002-09
- Primary completion
- 2002-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dipyridamole | Other / unclassified | 200 mg | — |
| Background | Aspirin | Small molecule | 25 mg | — |
Indications
No indication recorded.